AHR activation has been observed in the vessels of mice with CKD [51]; in human AVF, the TAK1 and p38 MAPK signaling pathways are significantly activated [40]; and finally, in a murine model of AVF, increased MCP-1 expression in the venous segment is accompanied by elevated AP-1 activity [11]. Here, CCL2 is linked to chronic kidney disease.